FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013189085> ?p ?o ?g. }

• W2013189085 endingPage "3306" @default.
• W2013189085 startingPage "3305" @default.
• W2013189085 abstract "The first clinical reports of a placental thyroid stimulator arose from studies indicating that placental tumors that secrete very large amount of human chorionic gonadotropin (hCG), hydatidiform moles and choriocarcinomas, were associated with hyperthyroidism [summarized by Yoshimura and Hershman (1)]. In 1967, Burger reported that impure, commercial hCG had thyroid-stimulating activity in a mouse bioassay (2). Several years later my laboratory (3) and that of Nisula (4) reported that highly purified hCG had activity in this bioassay. We found that the molar TSH was hCG (4). Because hCG varies in its carbohydrate composition, there has been considerable controversy in regard to the potency of these variants. hCG lacking its C-terminal tail, therefore closely resembling LH, is a more potent TSH than native hCG (5). Desialylated basic variants of hCG are more potent in binding to the TSH receptor than fully sialylated acidic hCG (6). However, the acidic hCG has a longer half-life in the circulation than the more basic partially desialylated hCG, and this may contribute to greater thyrotropic potency in humans (7). These studies mainly arose from patients with placental tumors or from a few patients with gestational thyrotoxicosis associated with high hCG levels. The possibility that hCG plays a role in regulation of the thyroid gland during normal pregnancy was first considered when there were more sensitive immunoassays for TSH. Braunstein and Hershman (8) reported that there was an inverse relationship between TSH and hCG at about 10–12 wk of pregnancy, the time of peak hCG levels. Harada et al. (9) further advanced this concept by showing the inverse relationship more clearly and amassing data showing an increase of free T4 and free T3 associated with the peak hCG. We postulated that hCG caused an increase of free thyroid hormone levels, thus suppressing TSH, albeit within the physiological range of serum TSH. Glinoer et al. (10), in a landmark study using a more sensitive TSH measurement, further refined the mirror image temporal relationship between hCG and TSH in normal pregnancies. Other reports also contributed to the concept that hCG is a thyroid stimulator in the early part of pregnancy when hCG levels are very high (11). In this issue of the Journal, Haddow et al. (12) have done a complex analysis of the relationship between hCG, TSH, and free T4 during the first trimester (wk 11–13) and second trimester (wk 15–18) in 9562 women with singleton pregnancies. They found that higher hCG levels were associated with a lower body mass index. This fits with the observation of Goodwin et al. (13) that hCG is higher in women with nausea of pregnancy and hyperemesis gravidarum than in women who do not have any nausea, assuming that weight gain is restricted by nausea. More importantly, the data of Haddow et al. further strengthen the role of hCG as a thyroid stimulator in normal pregnancy. At wk 11–13, higher hCG correlates with higher free T4 levels, although the relationship is a shallow slope, confirming the data of Glinoer et al. (10) that in normal pregnancy hCG only modestly increases free T4. The relationship between hCG and TSH is more difficult to appreciate in the complex analysis by Haddow et al. (12). It shows clearly that low TSH is associated with high levels of hCG, but when TSH is in the higher deciles, there is no correlation with hCG. My interpretation is simplistic. Placental secretion of hCG is not regulated by thyroid hormones. However, when hCG levels are high, they increase thyroid hormone secretion, and the negative feedback at the level of the pituitary suppresses TSH release. When TSH levels are in the higher part of the normal range, or perhaps slightly elevated for pregnancy, the contribution of hCG to increase free T4 and T3, resulting in lower TSH levels, is not sufficient to lower serum TSH significantly. Perhaps evolution designed the hCG system as a backup for stimulating the thyroid gland to produce essential amounts of thyroid hormone, but this backup system did not fully evolve to perfection." @default.
• W2013189085 created "2016-06-24" @default.
• W2013189085 creator A5087352271 @default.
• W2013189085 date "2008-09-01" @default.
• W2013189085 modified "2023-10-09" @default.
• W2013189085 title "The Role of Human Chorionic Gonadotropin as a Thyroid Stimulator in Normal Pregnancy" @default.
• W2013189085 cites W1964693382 @default.
• W2013189085 cites W1967375819 @default.
• W2013189085 cites W2006444741 @default.
• W2013189085 cites W2016408036 @default.
• W2013189085 cites W2023829594 @default.
• W2013189085 cites W2030962379 @default.
• W2013189085 cites W2031402418 @default.
• W2013189085 cites W2074511143 @default.
• W2013189085 cites W2076719524 @default.
• W2013189085 cites W2096594977 @default.
• W2013189085 doi "https://doi.org/10.1210/jc.2008-1461" @default.
• W2013189085 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18772462" @default.
• W2013189085 hasPublicationYear "2008" @default.
• W2013189085 type Work @default.
• W2013189085 sameAs 2013189085 @default.
• W2013189085 citedByCount "40" @default.
• W2013189085 countsByYear W20131890852013 @default.
• W2013189085 countsByYear W20131890852014 @default.
• W2013189085 countsByYear W20131890852015 @default.
• W2013189085 countsByYear W20131890852016 @default.
• W2013189085 countsByYear W20131890852017 @default.
• W2013189085 countsByYear W20131890852018 @default.
• W2013189085 countsByYear W20131890852019 @default.
• W2013189085 countsByYear W20131890852020 @default.
• W2013189085 countsByYear W20131890852021 @default.
• W2013189085 countsByYear W20131890852022 @default.
• W2013189085 countsByYear W20131890852023 @default.
• W2013189085 crossrefType "journal-article" @default.
• W2013189085 hasAuthorship W2013189085A5087352271 @default.
• W2013189085 hasBestOaLocation W20131890851 @default.
• W2013189085 hasConcept C126322002 @default.
• W2013189085 hasConcept C134018914 @default.
• W2013189085 hasConcept C2775948956 @default.
• W2013189085 hasConcept C2778782382 @default.
• W2013189085 hasConcept C2779234561 @default.
• W2013189085 hasConcept C526584372 @default.
• W2013189085 hasConcept C54355233 @default.
• W2013189085 hasConcept C71315377 @default.
• W2013189085 hasConcept C71924100 @default.
• W2013189085 hasConcept C86803240 @default.
• W2013189085 hasConceptScore W2013189085C126322002 @default.
• W2013189085 hasConceptScore W2013189085C134018914 @default.
• W2013189085 hasConceptScore W2013189085C2775948956 @default.
• W2013189085 hasConceptScore W2013189085C2778782382 @default.
• W2013189085 hasConceptScore W2013189085C2779234561 @default.
• W2013189085 hasConceptScore W2013189085C526584372 @default.
• W2013189085 hasConceptScore W2013189085C54355233 @default.
• W2013189085 hasConceptScore W2013189085C71315377 @default.
• W2013189085 hasConceptScore W2013189085C71924100 @default.
• W2013189085 hasConceptScore W2013189085C86803240 @default.
• W2013189085 hasIssue "9" @default.
• W2013189085 hasLocation W20131890851 @default.
• W2013189085 hasLocation W20131890852 @default.
• W2013189085 hasOpenAccess W2013189085 @default.
• W2013189085 hasPrimaryLocation W20131890851 @default.
• W2013189085 hasRelatedWork W1969849800 @default.
• W2013189085 hasRelatedWork W1993657484 @default.
• W2013189085 hasRelatedWork W1996631864 @default.
• W2013189085 hasRelatedWork W2011782404 @default.
• W2013189085 hasRelatedWork W2018249696 @default.
• W2013189085 hasRelatedWork W2024151106 @default.
• W2013189085 hasRelatedWork W2067533280 @default.
• W2013189085 hasRelatedWork W2067878402 @default.
• W2013189085 hasRelatedWork W2101899607 @default.
• W2013189085 hasRelatedWork W2163517010 @default.
• W2013189085 hasVolume "93" @default.
• W2013189085 isParatext "false" @default.
• W2013189085 isRetracted "false" @default.
• W2013189085 magId "2013189085" @default.
• W2013189085 workType "article" @default.